Downregulation of SRSF1 in cervical cancer cells with the AURKA kinase inhibitor VX-680 altered the splicing of Bcl-x to increase Bcl-xS, sensitizing the cells to VX-680-induced apoptosis (Moore et al., 2010). The gene discussed is BCL2L1; the disease is cervical cancer.